11-30 numbers shows 2 million shares short. Schwab shows this stock as a "hard to borrow". That doesn't add up? Wall Street manipulation playing short term swings just got surprised by the good news. If Pharmathene becomes too difficult (cost risk) to manipulate the big trend will start and I suspect it's a long ride to the upside over 2011.
GLTA, waiting to see if EOD provides lower entries. In my paranoid world I don't think Wall Street wants this one closing strong today.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.